HALO
Halozyme Therapeutics, Inc. ·
—
Market cap
—
52-week range
—
Volume
—
Previous close
—
Halozyme Therapeutics, Inc. (HALO) is held by 3 tracked hedge fund(s) and traded by 2 member(s) of Congress. Largest tracked holder: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC.
| Fund | % of portfolio | Shares | Value | Latest activity | Avg buy price | Date |
|---|---|---|---|---|---|---|
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
0.5% | 2.5M | $163M | ▲ 37% (+683K) | $66.58 | 2026-03-31 |
| SNYDER CAPITAL MANAGEMENT L P SNYDER CAPITAL MANAGEMENT L P |
2.9% | 2.3M | $150M | ▼ 3.2% (−76K) | $38.67 | 2026-03-31 |
| Stephens Investment Management Group LLC Stephens Investment Management Group LLC |
1.1% | 1.2M | $79M | — | $38.14 | 2026-03-31 |
Related ▾
FAQ ▾
Which hedge funds hold HALO?
Tracked holders include: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, SNYDER CAPITAL MANAGEMENT L P, Stephens Investment Management Group LLC.
How much smart money owns HALO?
3 tracked hedge fund(s) and 2 member(s) of Congress have disclosed positions.
Are members of Congress trading HALO?
Yes — 2 member(s) have disclosed HALO trades. See the Congress tab.
Where does this data come from?
SEC 13F filings (funds), Form 4 (insiders) and STOCK Act reports (Congress).
Sourced from SEC 13F, Form 4 & STOCK Act filings · Not investment advice ▾
Ownership from SEC filings; price from market data.
Published by WealthFile · Not investment advice.